Similar articles

• Response to methotrexate in a chronic inflammatory demyelinating polyradiculoneuropathy patient.

  Díaz-Manera J, Rojas-García R, Gallardo E, Illa I. Díaz-Manera J, et al. Muscle Nerve. 2009 Mar;39(3):386-8. doi: 10.1002/mus.21171. Muscle Nerve. 2009. PMID: 19208395
• Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study.

  RMC Trial Group. RMC Trial Group. Lancet Neurol. 2009 Feb;8(2):158-64. doi: 10.1016/S1474-4422(08)70299-0. Epub 2009 Jan 10. Lancet Neurol. 2009. PMID: 19136303 Clinical Trial.
• Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.

  Dalakas MC. Dalakas MC. J Peripher Nerv Syst. 2012 May;17 Suppl 2:34-9. doi: 10.1111/j.1529-8027.2012.00393.x. J Peripher Nerv Syst. 2012. PMID: 22548621 Review.
• Coincident membranous glomerulonephritis and chronic inflammatory demyelinating polyradiculoneuropathy: questioning the autoimmunity hypothesis.

  Smyth S, Menkes DL. Smyth S, et al. Muscle Nerve. 2008 Jan;37(1):130-5. doi: 10.1002/mus.20841. Muscle Nerve. 2008. PMID: 17614320
• Successful treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in systemic lupus erythematosus (SLE) with oral cyclophosphamide.

  Jasmin R, Sockalingam S, Shahrizaila N, Cheah TE, Zain AA, Goh KJ. Jasmin R, et al. Lupus. 2012 Sep;21(10):1119-23. doi: 10.1177/0961203312440346. Epub 2012 Mar 20. Lupus. 2012. PMID: 22433918 Review.